Literature DB >> 23471787

Secondary psychoses: an update.

Matcheri S Keshavan1, Yoshio Kaneko.   

Abstract

Psychotic disorders due to a known medical illness or substance use are collectively termed secondary psychoses. In this paper, we first review the historic evolution of the concept of secondary versus primary psychosis and how this distinction supplanted the earlier misleading classification of psychoses into organic and functional. We then outline the clinical features and approach to the diagnosis of secondary psychotic disorders. Features such as atypical presentation, temporal relation to detectable medical cause, evidence of direct physiological causal relationship to the etiological agent, and the absence of evidence of a primary psychotic illness that may better explain the presentation suggest consideration of a secondary psychosis. Finally, we discuss how careful studies of secondary psychotic disorders can help elucidate the pathophysiology of primary, or idiopathic, psychotic disorders such as schizophrenia. We illustrate this issue through a discussion of three secondary psychotic disorders - psychoses associated with temporal lobe epilepsy, velocardiofacial syndrome, and N-methyl D-aspartate (NMDA) receptor encephalitis - that can, respectively, provide neuroanatomical, genetic, and neurochemical models of schizophrenia pathogenesis.
Copyright © 2013 World Psychiatric Association.

Entities:  

Year:  2013        PMID: 23471787      PMCID: PMC3619167          DOI: 10.1002/wps.20001

Source DB:  PubMed          Journal:  World Psychiatry        ISSN: 1723-8617            Impact factor:   49.548


  154 in total

1.  Psychosis and progressing dementia: presenting features of a mitochondriopathy.

Authors:  S Amemiya; M Hamamoto; Y Goto; H Komaki; I Nishino; I Nonaka; Y Katayama
Journal:  Neurology       Date:  2000-08-22       Impact factor: 9.910

2.  Psychiatric symptom profiles of patients with epilepsy: a controlled investigation.

Authors:  K F Standage; G W Fenton
Journal:  Psychol Med       Date:  1975-05       Impact factor: 7.723

3.  Wilson's disease: clinical analysis of 71 cases and comparison with previous Chinese series.

Authors:  C C Huang; N S Chu
Journal:  J Formos Med Assoc       Date:  1992-05       Impact factor: 3.282

4.  Psychoses following war brain injuries.

Authors:  K A Achté; E Hillbom; V Aalberg
Journal:  Acta Psychiatr Scand       Date:  1969       Impact factor: 6.392

5.  Psychotic illness in patients diagnosed with velo-cardio-facial syndrome and their relatives.

Authors:  A E Pulver; G Nestadt; R Goldberg; R J Shprintzen; M Lamacz; P S Wolyniec; B Morrow; M Karayiorgou; S E Antonarakis; D Housman
Journal:  J Nerv Ment Dis       Date:  1994-08       Impact factor: 2.254

6.  The incidence and prognosis of central nervous system disease in systemic lupus erythematosus.

Authors:  J T Sibley; W P Olszynski; W E Decoteau; M B Sundaram
Journal:  J Rheumatol       Date:  1992-01       Impact factor: 4.666

7.  Drug interactions and pharmacogenetic reactions are the basis for chloroquine and mefloquine-induced psychosis.

Authors:  Joseph M Alisky; Elena L Chertkova; Kenneth A Iczkowski
Journal:  Med Hypotheses       Date:  2006-07-14       Impact factor: 1.538

Review 8.  Schizophrenia, "just the facts" what we know in 2008. 2. Epidemiology and etiology.

Authors:  Rajiv Tandon; Matcheri S Keshavan; Henry A Nasrallah
Journal:  Schizophr Res       Date:  2008-06-02       Impact factor: 4.939

Review 9.  Psychiatric manifestations in systemic lupus erythematosus.

Authors:  Ljudmila Stojanovich; Gisele Zandman-Goddard; Sanja Pavlovich; Natasa Sikanich
Journal:  Autoimmun Rev       Date:  2007-03-12       Impact factor: 9.754

10.  Enhancement of central dopaminergic activity in the kainate model of temporal lobe epilepsy: implication for the mechanism of epileptic psychosis.

Authors:  Nobuo Ando; Kiyoshi Morimoto; Takemi Watanabe; Takashi Ninomiya; Hiroshi Suwaki
Journal:  Neuropsychopharmacology       Date:  2004-07       Impact factor: 7.853

View more
  31 in total

1.  A young woman with seizures and psychosis.

Authors:  Sowjanya Naha; Kushal Naha; H Manjunath Hande; Ganapathiraman Vivek
Journal:  BMJ Case Rep       Date:  2014-07-09

2.  Secondary psychosis 3 months prior to the overt symptoms of multiple myeloma: a case report.

Authors:  Alexandra Flynn; Matthew Macaluso
Journal:  Prim Care Companion CNS Disord       Date:  2014

3.  A 54-year-old man with hallucinations and hearing loss.

Authors:  Claude Steriade; Steven L Shumak; Anthony Feinstein
Journal:  CMAJ       Date:  2014-06-30       Impact factor: 8.262

4.  Sleeping beauty syndrome presenting with insomnia.

Authors:  Sara Hussain; Khulood Al Jarman; Sahar Hussain
Journal:  BMJ Case Rep       Date:  2018-10-12

5.  The relationship between prior psychiatric diagnosis and brain cancer diagnosis in the U.S. military health system.

Authors:  Julie A Bytnar; Jie Lin; Brett J Theeler; Ann I Scher; Craig D Shriver; Kangmin Zhu
Journal:  Cancer Causes Control       Date:  2022-07-15       Impact factor: 2.532

6.  When No Treatment Is the Treatment: Mental Illness-Related Case Report.

Authors:  Colette Raphaël; Ofer Agid
Journal:  Can J Hosp Pharm       Date:  2022

Review 7.  Organic psychosis: The pathobiology and treatment of delusions.

Authors:  Eileen Maria Joyce
Journal:  CNS Neurosci Ther       Date:  2018-05-15       Impact factor: 5.243

8.  Frontal lobe meningioma presenting with schizophrenia-like symptoms: an organic cause of psychotic disorder.

Authors:  Chawisa Suradom; Sirijit Suttajit; Atiwat Soontornpun; Manee Pinyopornpanish
Journal:  BMJ Case Rep       Date:  2020-04-28

9.  Psychosis Crisis Associated with Thyrotoxicosis due to Graves' Disease.

Authors:  Lilibet Urias-Uribe; Emmanuel Valdez-Solis; Claudia González-Milán; Claudia Ramírez-Rentería; Aldo Ferreira-Hermosillo
Journal:  Case Rep Psychiatry       Date:  2017-06-11

Review 10.  Anti-Alpha-Amino-3-Hydroxy-5-Methyl-4-Isoxazolepropionic Acid Receptor Encephalitis: A Review.

Authors:  Tian-Yi Zhang; Meng-Ting Cai; Yang Zheng; Qi-Lun Lai; Chun-Hong Shen; Song Qiao; Yin-Xi Zhang
Journal:  Front Immunol       Date:  2021-05-21       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.